Mohamed Kharfan-Dabaja, MD, MBA
@MKD_BMT
Vice Chair of Hematology. Director of Blood Marrow and Transplantation and Cellular Therapies.@MayoClinic @MayoCancerCare
ID:1393292267323076612
https://mayocl.in/3CrUJdl 14-05-2021 19:50:31
327 Tweets
1,6K Followers
693 Following
CAR T-cell Therapy in Mantle cell with sCNS Involvement.
Active disease PFS only 25%, without active disease about 33%. Perhaps needs post CT maintenance?
Mazyar Shadman, MD MPH Gulrayz Ahmed Farrukh Awan Tim Fenske Madiha Iqbal MD Mohamed Kharfan-Dabaja, MD, MBA MCW Cancer Center #lymsm #CART
ashpublications.org/bloodadvances/…
What are the outcomes and unmet needs of patients with transfusion-dependent thalassemia?
Ali Taher of American University of Beirut Medical Center shares a global perspective on this in an interview from #EBMT24 . 🌎
Click here to watch:
👉 ow.ly/JyIU50RhYO2
#Thalassemia #Hematology The EBMT
Today was part I of Dr #Robert_Kyle memoire of his journey to medicine narrated by himself ♥️ under #Hematology_heritage series. The spark to go into medicine was a book written by #Mayo_Brothers he read in high school 👏 1944.
Mayo Clinic
thedigitalpress.org/kyle_memoir/
Our review on 'Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?'
tandfonline.com/doi/full/10.10…
Thank you, Mohamed Kharfan-Dabaja, MD, MBA and Dr Al-kadhimi
See below some take-home messages:
🧵🧵
Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations.
just Published in Clinical Hematology International the official journal of IACH Ola Oluwole Bipin Savani Uriel Suárez chi.scholasticahq.com/article/115793
Efficacy of autologous and allogeneic hematopoietic cell transplantation in APL: systemic review and meta-analysis
sciencedirect.com/science/articl…
A big shout out to Razan Mohty for leading this effort! Congratulation to all co-authors at Mayo Clinic, Florida.
Highlights:
10% of pts
“CAR-T Therapy for CLL: What is the supporting evidence so far?” A comprehensive review published in Clin Hematol Int. Official journal of IACH
CLL Advocates Network Razan Mohty Mohamed Kharfan-Dabaja, MD, MBA @HealthTreeCLL ELLyE l’Association #Lymphomes #LLC chi.scholasticahq.com/article/88382-…
Congratulations to 2024 Fellows of ASTCT (FASTCT) Betty Ky Hamilton of Cleveland Clinic and J Holter Chakrabarty of the OU Health Stephenson Cancer Center. #Tandem24
Congratulations to ASTCT Survivorship SIG Lifetime Achievement Award winner Bipin Savani of Vanderbilt University. 🎉 Thank you for your contributions to the transplantation and cellular therapy field. #Tandem24
Congratulations to ASTCT Committee on Practice Guidelines Distinguished Service Award winner Ambuj Kumar of USF Health Medicine. 🎉 Thank you for your contributions to the transplantation and cellular therapy field. #Tandem24
This procedure replaces damaged cells with healthy stem cells, collected either from the patient or a generous donor. It's a dynamic treatment that can also tackle an array of blood disorders, including anemias and immune deficiencies. #InnovationStartsAtMayo
When he isn't at the forefront of blood and cellular therapies, Dr. Kharfan-Dabaja enjoys traveling and spending time with his family. Meet the man behind the medicine. #InnovationStartsAtMayo
Learn more: mayocl.in/3CrUJdl
In the world of medicine, information is power. At Mayo Clinic, we aim to empower patients with resources, guides, and the most up-to-date information about diseases, conditions, and treatments. Knowledge is the first step towards healing. #InnovationStartsAtMayo